| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/28/1992 | CA2052287A1 Tricyclic heterocyclic compounds, their production and use |
| 03/28/1992 | CA2052069A1 Fibrinogen receptor antagonists |
| 03/28/1992 | CA2052043A1 Fibrinogen receptor antagonists |
| 03/27/1992 | WO1992005176A1 Xanthines |
| 03/27/1992 | WO1992005175A1 Xanthine derivatives |
| 03/27/1992 | CA2092430A1 Xanthine derivatives |
| 03/27/1992 | CA2092429A1 Xanthines |
| 03/27/1992 | CA2052234A1 Heterocyclic alkyl amines, process for their preparation and pharmaceutical compositions holding same |
| 03/27/1992 | CA2052231A1 Sebaceous excitosecretory agent |
| 03/27/1992 | CA2051261A1 Cardiopulmonary bypass and organ transplant using a potassium channel activator |
| 03/26/1992 | WO1992005173A1 Substituted tricyclic compounds |
| 03/26/1992 | WO1992005148A1 Imidazol derivatives, process for their preparation and their applications |
| 03/26/1992 | WO1992004909A1 Pharmaceutical composition comprising cd4 and a polyanionic anti-hiv agent and use thereof |
| 03/26/1992 | DE4030165A1 Neue verwendung von fipexid New use of fipexid |
| 03/26/1992 | CA2092309A1 Imidazol derivatives, process for their preparation and their applications |
| 03/26/1992 | CA2092093A1 Pharmaceutical composition comprising cd4 and a polyanionic anti-hiv agent and use thereof |
| 03/26/1992 | CA2091690A1 Substituted tricyclic compounds |
| 03/26/1992 | CA2052191A1 Benzene, pyridine and pyrimidine derivative |
| 03/26/1992 | CA2052125A1 Heterocyclic derivatives |
| 03/26/1992 | CA2052097A1 Antiviral agent |
| 03/25/1992 | WO1992004899A1 Methods |
| 03/25/1992 | EP0477141A1 Heteroarylmethylbenzols aromatase inhibitors |
| 03/25/1992 | EP0477061A1 Tablet of Isosorbide-5-Mononitrate with sustained release and its process of preparation |
| 03/25/1992 | EP0477049A1 Amido-3-pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/25/1992 | EP0476994A1 7-Oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 03/25/1992 | EP0476953A2 Viral targeted destruction of neoplastic cells |
| 03/25/1992 | EP0476944A1 Aromatase inhibiting 4(5)-imidazoles |
| 03/25/1992 | EP0476935A1 New indol and indoline derivatives |
| 03/25/1992 | EP0476854A1 Pharmaceutical composition for inhibiting platelet aggregation |
| 03/25/1992 | EP0476846A2 Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy |
| 03/25/1992 | EP0476711A2 Use of 5-fluorouracil for the treatment of AIDS |
| 03/25/1992 | EP0476696A1 A superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
| 03/25/1992 | EP0476682A1 Isoprenoid phospholipase A2 inhibitors and preparations comprising same |
| 03/25/1992 | EP0476658A1 1-Phenyl-3-phenyl-2-propyne-1-ones |
| 03/25/1992 | EP0476646A1 Calcium uptake inhibitors |
| 03/25/1992 | EP0476645A1 Calcium uptake inhibitors |
| 03/25/1992 | EP0476515A1 New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/25/1992 | EP0476493A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia |
| 03/25/1992 | EP0476391A2 Anti-AIDS virus composition containing cepharanthine as active compound |
| 03/25/1992 | EP0476205A1 Sustained release morphine preparation for rectal administration |
| 03/25/1992 | EP0476156A1 Solid oral preparation containing catechol compound |
| 03/25/1992 | EP0476120A1 PROCESS FOR PREPARING EQUIMOLAR SALTS OF A DICARBOXYLIC -g(a)-AMINO ACID AND A DIVALENT METAL, MAGNESIUM ASPARTATE SALT OBTAINED BY SAID PROCESS AND ITS APPLICATIONS. |
| 03/25/1992 | EP0476054A1 Method for treating viral infection |
| 03/25/1992 | EP0476016A1 Therapeutically useful 2-aminotetralin derivatives |
| 03/25/1992 | EP0476011A1 Photosensitizing diels-alder porphyrin derivatives |
| 03/25/1992 | EP0475992A1 Therapeutic nucleosides |
| 03/25/1992 | EP0172880B1 Use of long chain and medium chain triglycerides |
| 03/25/1992 | CN1059728A O-methyl derivatives of azithromycin, process and intermediate for their preparation, and use thereof in preparation of pharmaceuticals |
| 03/25/1992 | CN1059725A Methylamino pterin derivatives |
| 03/25/1992 | CN1059724A Tricyclic compounds |
| 03/25/1992 | CN1059723A Heterocyclic derivatives |
| 03/25/1992 | CN1059722A 3-aryl-4(3h) quinazolinone cck antagonists and pharmaceutical formulations thereof |
| 03/25/1992 | CN1059721A Process for preparation of 6-(3-substitutedamino-propionyl)-7-deacetylforskolin |
| 03/25/1992 | CN1059717A Serotonin 5htia agonists |
| 03/25/1992 | CN1059661A Desensitizing paste for curing primery dentine hypersensitive |
| 03/25/1992 | CN1059659A Diagnosis and treatment of viral hepatitis |
| 03/25/1992 | CN1015988B New cephalosporins and process for their preparation |
| 03/25/1992 | CN1015987B Preparation method of bridged two-rings dicarboximide compound used for anti-worries and anti-depression drug |
| 03/25/1992 | CN1015982B Novel bicyclic lactam pharmacologically active compositions thereof process for the preparation thereof and their medical use |
| 03/25/1992 | CA2092177A1 Methods |
| 03/25/1992 | CA2050826A1 Microbial preparation of 13.beta.-13-deoxy-22,23-dihydro avermectin-b1a/b1b a glycone |
| 03/25/1992 | CA2050821A1 Process for making 17-.beta. alkanoyl 3-oxo-4-aza-5-alpha-androst- 1-enes |
| 03/24/1992 | US5099063 Certain phosphinic acid derivatives having antibacterial activity |
| 03/24/1992 | US5099034 Nervous system and cardiovascular disorders |
| 03/24/1992 | US5099015 Trifluoromethyl 1-carba(1-dethia)cephems |
| 03/24/1992 | US5099012 Antiischemic agents |
| 03/24/1992 | US5098935 Carcinostatic or antitumor antibiotic, conagenin, and production and uses thereof |
| 03/24/1992 | US5098934 Method of relieving pain with mercaptoalkanamides |
| 03/24/1992 | US5098932 Cyclic ether derivatives |
| 03/24/1992 | US5098930 Heterocyclic derivatives |
| 03/24/1992 | US5098928 Antilipemic agents and treatment of arteriosclerosis |
| 03/24/1992 | US5098927 Antiretroviral agent, method of use thereas, and method of preparation |
| 03/24/1992 | US5098925 Neurological disorders in mammals |
| 03/24/1992 | US5098924 Hypotensive agents and angiotensin II inhibitors |
| 03/24/1992 | US5098923 Aromatase inhibiting 4(5)-imidazoles |
| 03/24/1992 | US5098922 Anticonvulsants |
| 03/24/1992 | US5098921 Antitumor agents |
| 03/24/1992 | US5098920 Hypotensive agents and treatment of congestive heart failure |
| 03/24/1992 | US5098919 Liver disease |
| 03/24/1992 | US5098916 Central nervous system as antiischemic agents, dystonia and as anticonvulsants |
| 03/24/1992 | US5098914 Treating with piperidine alkaloids from Solenopsin |
| 03/24/1992 | US5098912 Bactericides for grampositive bacteria |
| 03/24/1992 | US5098911 Hemihydrate of 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride |
| 03/24/1992 | US5098910 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 03/24/1992 | US5098909 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction |
| 03/24/1992 | US5098908 Drugs for treatment of acne, seborrhea, female hirsurism and benign prostatic hypertropy |
| 03/24/1992 | US5098907 Nonionic surfactants |
| 03/24/1992 | US5098904 Cerebral function enhancing pyrimidinyl derivatives |
| 03/24/1992 | US5098903 Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents |
| 03/24/1992 | US5098902 Administering 5-bromo-4- 4-morpholinyl!-2-pyridinamine or 4- 4-morpholinyl-2- 1-piperazinyl!thieno 3,2-d!pyrimidine for cognitive activators |
| 03/24/1992 | US5098900 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it |
| 03/24/1992 | US5098899 Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites |
| 03/24/1992 | US5098898 Peroxide inhibitors and antioxidants for foods |
| 03/24/1992 | US5098896 Aliphatic alcohols for treatment of vision defects after laser treatment |
| 03/24/1992 | US5098895 Benzonaphthalene derivatives, a process for their preparation and their use in therapeutic and cosmetic compositions |
| 03/24/1992 | US5098889 Cognition activators, angiotensin converting enzyme inhibitors |
| 03/24/1992 | US5098888 Cholinergic agents and antispasmodic agents |
| 03/24/1992 | US5098714 Osmotic, oral dosage form for fertility control |
| 03/24/1992 | US5098701 Crosslinked pyridinomethacrylate polymers |
| 03/24/1992 | US5098692 Gadolium complexes with N6-carboxymethyl-N3,N9-bis(methyl carbamoyl-methyl)-3,6,9-triazaundecanedioic acid and complexes with calcium |